DSpace@İnönü

Prognostic factors of perioperative FLOT regimen in operable gastric and

Basit öğe kaydını göster

dc.contributor.author Erol, C
dc.contributor.author Sakin, A
dc.contributor.author Basoglu, T
dc.contributor.author Ozden, E
dc.contributor.author Cabuk, D
dc.contributor.author Dogan, M
dc.contributor.author Oksuzoglu, B
dc.contributor.author Yildirim, HC
dc.contributor.author Oner, I
dc.contributor.author Eryilmaz, MK
dc.contributor.author Dulgar, O
dc.contributor.author Aydin, D
dc.contributor.author Dogan, N
dc.contributor.author Ozen, M
dc.contributor.author Hacibekiroglu, I
dc.contributor.author Ozdemir, N
dc.contributor.author Gurler, F
dc.contributor.author Paksoy, N
dc.contributor.author Karabulut, S
dc.contributor.author Aksoy, A
dc.contributor.author Hizal, M
dc.contributor.author Kahraman, S
dc.contributor.author Sen, E
dc.contributor.author Paydas, S
dc.contributor.author Cilbir, E
dc.contributor.author Firat, F
dc.contributor.author Akdeniz, N
dc.contributor.author Ozcelik, M
dc.contributor.author Oyman, A
dc.contributor.author Baytemur, NK
dc.contributor.author Acar, R
dc.contributor.author Almuradova, E
dc.contributor.author Karabulut, B
dc.contributor.author Sakalar, T
dc.contributor.author Arak, H
dc.contributor.author Degerli, E
dc.contributor.author Turker, S
dc.contributor.author Alan, O
dc.contributor.author Er, O
dc.contributor.author Tasci, ES
dc.contributor.author Demir, N
dc.contributor.author Cavdar, E
dc.contributor.author Turhal, S
dc.contributor.author Dede, DS
dc.contributor.author Akinci, MB
dc.contributor.author Yalcin, B
dc.contributor.author Yumuk, F
dc.contributor.author Yalcin, S
dc.contributor.author Sendur, MAN
dc.date.accessioned 2023-01-02T08:53:11Z
dc.date.available 2023-01-02T08:53:11Z
dc.date.issued 2022
dc.identifier.uri http://hdl.handle.net/11616/86978
dc.description.abstract Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in real-life gastric and GEJ tumors.
dc.description.abstract Materials and methods: The data of patients who were treated with perioperative FLOT chemotherapy were retrospectively analyzed from 34 different oncology centers in Turkey. Baseline clinical and demographic characteristics, pretreatment laboratory values, histological and molecular characteristics were recorded.
dc.description.abstract Results: A total of 441 patients were included in the study. The median of age our study population was 60 years. The majority of patients with radiological staging were cT3-4N(+) (89.9%, n = 338). After median 13.5 months (IQR: 8.5-20.5) follow-up, the median overall survival was NR (95% CI, NR to NR), and median disease free survival was 22.9 (95% CI, 18.6 to 27.3) months. The estimated overall survival at 24 months was 62%. Complete pathological response (pCR) and near pCR was achieved in 23.8% of all patients. Patients with lower NLR or PLR have significantly longer median OS (p = 0.007 and p = 0.033, respectively), and patients with lower NLR have significantly longer median DFS (p = 0.039), but PLR level did not affect DFS (p = 0.062). The OS and DFS of patients with better ECOG performance scores and those who could receive FLOT as adjuvant chemotherapy instead of other regimens were found to be better. NLR was found to be independent prognostic factor for OS in the multivariant analysis. At least one adverse event reported in 57.6% of the patients and grade 3-4 toxicity was seen in 23.6% patients.
dc.description.abstract Conclusion: Real-life perioperative FLOT regimen in operable gastric and GEJ tumors showed similar oncologic outcomes compared to clinical trials. Better performance status, receiving adjuvant chemotherapy as same regimen, low grade and low NLR and PLR improved outcomes in real-life. However, in multivariate analysis, only NLR affected OS.
dc.source TURKISH JOURNAL OF MEDICAL SCIENCES
dc.title Prognostic factors of perioperative FLOT regimen in operable gastric and
dc.title gastroesophageal junction tumors: real-life data (Turkish Oncology
dc.title Group)


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster